The FDA's recent move was a giant step toward a calamitous new drug approval policy.

Patients would be better off if the FDA focused on unearthing information to help doctors determine which pills will perform the best for each individual patient.

Patients would benefit greatly if the Food and Drug Administration let doctors make decisions for patients based on individual needs.

Congress must wean the FDA from its misapplied "first, do no harm" principle, which causes far more harm than it prevents.

An examination of Cox-2 class drugs for assessing Merck's decision to withdraw Vioxx.

New research findings and a thorough reassessment of older research indicate that drugs like Vioxx can have many important benefits and great potential for addressing serious problems.

The FDAAmendments Act of 2007 will bring the most important changes in FDA regulation in at least a decade, but it is an unnecessary law.